Elena Cini

Via A. Moro 2
Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

An Integrated NMR Approach for Evaluating Linker-Payload Conjugation with Monoclonal Antibodies.

An Integrated NMR Approach for Evaluating Linker-Payload Conjugation with Monoclonal Antibodies.

Journal: Bioconjugate chemistry

Published: February 06, 2026

Natural products as payloads for antibody-drug conjugates: Cyclopamine linked to cetuximab for hedgehog pathway inhibition.

Natural products as payloads for antibody-drug conjugates: Cyclopamine linked to cetuximab for hedgehog pathway inhibition.

Journal: Bioorganic chemistry

Published: September 15, 2025

Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders.

Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders.

Journal: European journal of medicinal chemistry

Published: July 15, 2025

ProTide-enabled antibody-drug conjugates: A novel platform for the targeted delivery of phosphorylated drugs.

ProTide-enabled antibody-drug conjugates: A novel platform for the targeted delivery of phosphorylated drugs.

Journal: Bioorganic chemistry

Published: July 03, 2025

A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides.

A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides.

Journal: Chemical science

Published: March 06, 2024

Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules.

Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules.

Journal: Biomolecules

Published: December 18, 2023

A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery.

A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery.

Journal: Chemical communications (Cambridge, England)

Published: August 31, 2022

Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor.

Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor.

Journal: International journal of molecular sciences

Published: July 22, 2022

Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening.

Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening.

Journal: ACS medicinal chemistry letters

Published: May 26, 2022

Pulmonary Function and Psychological Burden Three Months after COVID-19: Proposal of a Comprehensive Multidimensional Assessment Protocol.

Pulmonary Function and Psychological Burden Three Months after COVID-19: Proposal of a Comprehensive Multidimensional Assessment Protocol.

Journal: Healthcare (Basel, Switzerland)

Published: February 14, 2022

Synthesis of 2-Substitued Indoles via Pd-Catalysed Cyclization in an Aqueous Micellar Medium.

Synthesis of 2-Substitued Indoles via Pd-Catalysed Cyclization in an Aqueous Micellar Medium.

Journal: Molecules (Basel, Switzerland)

Published: May 17, 2021

Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition.

Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition.

Journal: Chemical communications (Cambridge, England)

Published: January 12, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026